Molina Healthcare Raises Full-Year EPS Guidance to $5.25, Shares Drop 9% on Limited Outlook

Summary

Molina Healthcare raised its FY26 adjusted EPS guidance to at least $5.25 despite a 74% drop in Q2 GAAP EPS and a 4.8% revenue decline PUBT+ 2. Shares plunged 9% as investors reacted to a widened medical care ratio and projected losses from a new Florida Medicaid contract Reuters+ 2.

Impact Analysis

The market just called management’s bluff. Usually, a guidance hike triggers a rally, but this 9% post-earnings dive tells you everything about the low quality of that ‘beat’ Reuters+ 2. So basically, they’re raising the floor to $5.25, but the underlying business looks leaky Reuters. A 74% GAAP earnings collapse and shrinking revenue aren’t things you can just adjust away PUBT.

The interesting part isn’t the guidance; it’s the execution risk. They are taking immediate hits on the new Florida Medicaid contract and retreating from Medicare Advantage Reuters. While CEO Zubretsky claims Medicaid costs are finally stabilizing, the widened medical care ratio suggests the margin of error is razor-thin PUBT. Market’s missing that this isn’t a growth story anymore—it’s a restructuring play. I’d read this as management trying to buy time while the Marketplace business faces real pressure. I’m not catching this falling knife until we see the medical cost ratio actually trend down. For now, the ‘Hold’ consensus feels exactly right Market Beat.